| |
| |
|
| Insider
Information: |
Latham John A |
| Relationship: |
Chief Scientific Officer |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
244,180 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,610,118 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
244,180 |
|
|
| Total
Value |
$4,610,118 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alder Biopharmaceuticals Inc |
ALDR |
Chief Scientific Officer |
2018-11-30 |
244,180 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-11-30 |
4 |
A |
$9.35 |
$4,553 |
D/D |
487 |
244,180 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-11-01 |
4 |
AS |
$13.40 |
$335,589 |
D/D |
(25,002) |
243,693 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-11-01 |
4 |
OE |
$6.77 |
$227,954 |
D/D |
25,002 |
268,695 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-10-01 |
4 |
AS |
$15.25 |
$386,006 |
D/D |
(24,999) |
243,693 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-10-01 |
4 |
OE |
$3.47 |
$109,108 |
D/D |
24,999 |
268,692 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-09-04 |
4 |
OE |
$3.47 |
$86,622 |
D/D |
24,999 |
268,692 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-09-04 |
4 |
AS |
$17.99 |
$449,680 |
D/D |
(24,999) |
243,693 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-08-01 |
4 |
OE |
$3.47 |
$86,622 |
D/D |
24,999 |
268,692 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-08-01 |
4 |
AS |
$19.55 |
$488,768 |
D/D |
(24,999) |
243,693 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-07-02 |
4 |
OE |
$3.47 |
$86,622 |
D/D |
24,999 |
268,692 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-07-02 |
4 |
AS |
$15.48 |
$387,002 |
D/D |
(24,999) |
243,693 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-06-01 |
4 |
AS |
$17.76 |
$446,356 |
D/D |
(24,999) |
243,693 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-06-01 |
4 |
OE |
$3.47 |
$109,121 |
D/D |
24,999 |
268,692 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2017-11-30 |
4 |
A |
$9.35 |
$4,413 |
D/D |
472 |
243,208 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2017-05-31 |
4 |
A |
$13.09 |
$4,359 |
D/D |
333 |
242,736 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-12-01 |
4 |
AS |
$22.64 |
$82,812 |
D/D |
(3,636) |
242,403 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-12-01 |
4 |
OE |
$1.65 |
$5,999 |
D/D |
3,636 |
246,039 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-11-09 |
4 |
OE |
$1.65 |
$16,500 |
D/D |
10,000 |
252,200 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-11-09 |
4 |
AS |
$30.18 |
$301,839 |
D/D |
(10,000) |
242,200 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-10-03 |
4 |
AS |
$31.00 |
$313,152 |
D/D |
(10,000) |
242,200 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-10-03 |
4 |
OE |
$1.65 |
$16,500 |
D/D |
10,000 |
252,200 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-09-01 |
4 |
AS |
$32.49 |
$324,949 |
D/D |
(10,000) |
242,200 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-09-01 |
4 |
OE |
$1.65 |
$16,500 |
D/D |
10,000 |
252,200 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-08-01 |
4 |
OE |
$1.65 |
$16,500 |
D/D |
10,000 |
252,200 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-08-01 |
4 |
S |
$31.75 |
$113,484 |
D/D |
(3,574) |
242,232 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
